1 completed, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Maxim Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver aldesleukin, histamine dihydrochloride - Melanoma (Skin), Metastatic Cancer | Phase 3 | Unknown | Maxim Pharmaceuticals | 2002-09-01 | 2013-12-18 | |
| Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia aldesleukin, histamine dihydrochloride - Leukemia | Phase 3 | Completed | Maxim Pharmaceuticals | 360 | 1998-07-01 | 2013-11-06 |
Leukemia (1) · Melanoma (1) · Neoplasm Metastasis (1)
Histamine (2) · aldesleukin (2)
Canada (2) · Germany (2) · United Kingdom (2) · United States (2) · Australia (1) · Denmark (1) · Estonia (1) · Finland (1) · France (1) · Israel (1) · New Zealand (1) · Sweden (1)
Barbara Berryhill (1) · John A. Glaspy, MD, MPH (1)